-
公开(公告)号:US20220389047A1
公开(公告)日:2022-12-08
申请号:US17775864
申请日:2020-11-13
Inventor: Hirohiko ISE , Saori MATSUO
Abstract: An O-GlcNAcylated protein-like substance having an N-acetylglucosamine unit, and at least one unit selected from the group consisting of a carboxy group-containing radically polymerizable unit, a styrene unit, a polyethylenimine unit, a poly-L-lysine unit, and a biotin unit; and a fibrosis therapeutic drug containing the O-GlcNAcylated protein-like substance.
-
公开(公告)号:US20170095564A1
公开(公告)日:2017-04-06
申请号:US15312507
申请日:2015-05-19
Applicant: SOMAR CORPORATION
Inventor: Hirohiko ISE
CPC classification number: A61K49/0052 , A61K41/00 , A61K47/36 , A61K47/50 , A61K47/542 , A61K47/545 , A61K47/549 , A61K47/61 , A61K47/6905 , A61K49/00 , A61K49/0043 , A61K49/0076 , C08F12/26
Abstract: An N-acetylglucosamine sugar chain group-containing compound which can easily reach cells/sites on which a vimentin and/or desmin protein(s) is/are exposed, which compound has excellent affinity to N-acetylglucosamine sugar chain-recognizing proteins; a drug delivery carrier compound comprising the compound: a preparation using the drug delivery earner compound; and a drug delivery system; are provided. These are an N-acetylglucosamine sugar chain group-containing compound having a weight average molecular weight within the range of 15,000 to 100,000; a drug delivery carrier compound comprising the compound; a preparation using the drug delivery carrier compound; and a drug delivery system.
-